CEPHALON

cephalon-logo

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.

#People #Financial #Website #More

CEPHALON

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
1987-01-01

Address:
Malvern, Pennsylvania, United States

Country:
United States

Website Url:
http://www.cephalon.com

Total Employee:
1001+

Status:
Closed

Contact:
610-344-0200

Email Addresses:
[email protected]

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GlobalSign Domain Verification Shockwave Flash Embed Akamai Hosted ATT



Current Advisors List

charles-homcy_image

Charles Homcy Member of the Board of Directors @ Cephalon
Board_member

Current Employees Featured

not_available_image

Frank Baldino, Jr.
Frank Baldino, Jr. Chairman & CEO @ Cephalon
Chairman & CEO

piyush-patel_image

Piyush Patel
Piyush Patel Director @ Cephalon
Director
1996-01-01

Founder


noubar-afeyan_image

Noubar Afeyan

Stock Details


Company's stock symbol is NASDAQ:CEPH

Acquisitions List

Date Company Article Price
2011-03-29 ChemGenex Pharmaceuticals ChemGenex Pharmaceuticals acquired by Cephalon 225 M USD
2011-03-21 Gemin X Pharmaceuticals Gemin X Pharmaceuticals acquired by Cephalon 525 M USD
2010-02-23 Ception Therapeutics Ception Therapeutics acquired by Cephalon 250 M USD
2010-02-01 Mepha Pharma Mepha Pharma acquired by Cephalon 615.4 M USD
2009-08-11 Arana Therapeutics Arana Therapeutics acquired by Cephalon N/A
2005-05-12 Salmedix Salmedix acquired by Cephalon 160 M USD

Investments List

Date Company Article Money raised
2011-02-25 SymBio Pharmaceuticals Cephalon investment in Series E - SymBio Pharmaceuticals 2 B JPY
2009-12-11 SymBio Pharmaceuticals Cephalon investment in Venture Round - SymBio Pharmaceuticals 2.2 B JPY
2009-04-15 SymBio Pharmaceuticals Cephalon investment in Venture Round - SymBio Pharmaceuticals 888.48 M JPY
2008-04-03 SymBio Pharmaceuticals Cephalon investment in Corporate Round - SymBio Pharmaceuticals 618 M USD
2007-11-02 SymBio Pharmaceuticals Cephalon investment in Venture Round - SymBio Pharmaceuticals 717.8 M JPY
2003-02-07 TransTech Pharma Cephalon investment in Venture Round - TransTech Pharma 24.5 M USD

Official Site Inspections

http://www.cephalon.com

  • Host name: 143-13-66-68.static.unitasglobal.net
  • IP address: 68.66.13.143
  • Location: Lenexa United States
  • Latitude: 38.9523
  • Longitude: -94.7395
  • Metro Code: 616
  • Timezone: America/Chicago
  • Postal: 66227

Loading ...

More informations about "Cephalon"

Cephalon - Wikipedia

Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauerโ€”all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was establisheโ€ฆSee details»

Cephalon Company Profile 2024: Valuation, Investors

The current revenue for Cephalon is . Who are Cephalonโ€™s investors? Ben Franklin Technology Partners of Southeastern Pennsylvania , InterWest Partners , New Leaf Venture , New Science Ventures , and Oak Investment Partners โ€ฆSee details»

Cephalon - LinkedIn

Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of โ€ฆSee details»

Cephalon Company Profile | Management and Employees List

Cephalon Profile and History. Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of โ€ฆSee details»

Cephalon, Inc. - Encyclopedia.com

Cephalon seeks to discover, develop and market innovative products to treat neurological and sleep disorders, cancer, and pain. The company is committed to providing patients and the โ€ฆSee details»

Cephalon: Contact Details and Business Profile - RocketReach

Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of โ€ฆSee details»

Cephalon - Funding, Financials, Valuation & Investors - Crunchbase

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the. Search Crunchbase. ... Which industries has โ€ฆSee details»

Cephalon - Crunchbase Company Profile & Funding

Cephalon is a medical equipment manufacturer that works primarily in electrodiagnostic devices for neuro and imaging applications. Nørresundby , Nordjylland , Denmark 11-50See details»

Cephalon - bionity.com

Cephalon is a component of the S&P MidCap 400 stock index, and is included in the Fortune 1000 list of U.S. companies based upon annual revenues for 2006. The company's early โ€ฆSee details»

Cephalo Company Profile: , Investments, Contact Information, โ€ฆ

Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of โ€ฆSee details»

Cephalon, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Drugmaker Cephalon had the FDA's approval to market these drugs for years under brand names like Actiq , a sweetened lozenge on a stick, or Fentora , a tablet that dissolves in the mouth. โ€ฆSee details»

Cephalon, Inc. - PHARMACEUTICAL ONLINE

Mar 27, 2001 Cephalon seeks to discover, develop and market innovative products to treat neurological disorders, sleep disorders and cancer. The company is committed to providing โ€ฆSee details»

Cephalon - Overview, News & Similar companies | ZoomInfo.com

Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing โ€ฆSee details»

CEPHALON, INC. Company Profile | Salt Lake City, UT

Find company research, competitor information, contact details & financial data for CEPHALON, INC. of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»

Cephalon, Inc. -- Company History

Statistics: Public Company Incorporated: 1987 Employees: 650 Sales: $111.79 million (2000) Stock Exchanges: NASDAQ Ticker Symbol: CEPH NAIC: 54171 Research and Development โ€ฆSee details»

Cephalon - Overview, News & Similar companies | ZoomInfo.com

Cephalon Inc is a company that operates in the Pharmaceuticals industry. It employs 21-50 people and has $5M-$10M of revenue. The company is headquartered in Parsippany, New โ€ฆSee details»

Cephalon Company Profile - Office Locations, Competitors ... - Craft

Cephalon is a supplier of electrodiagnostic devices and supplies to the hospitals. It provides systems and solutions in the areas of neuro diagnostics, intensive care, sleep diagnostics, โ€ฆSee details»

Cephalon - Contacts, Employees, Board Members, Advisors

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

Cephalon - Overview, News & Similar companies | ZoomInfo.com

Cephalon Inc is a company that operates in the Oil & Energy industry. It employs 21-50 people and has $10M-$25M of revenue. The company is headquar tered in Overland Park, Kansas. โ€ฆSee details»